Douglass Winthrop Advisors, LLC Pfizer Inc Transaction History

Douglass Winthrop Advisors, LLC

$4.96 Billion
Q4 2024

A detailed history of Douglass Winthrop Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 85,776 shares of PFE stock, worth $2.19 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

85,776

Previous 48,123 78.24%

Holding current value

$2.19 Million

Previous $1.39 Million 63.43%

% of portfolio

0.05%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$24.8 - $30.19 $933,794 - $1.14 Million	37,653 Added 78.24%	85,776 $2.28 Million
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $188,803 - $213,954	6,816 Added 16.5%	48,123 $1.39 Million
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $99,524 - $116,624	-3,940 Reduced 8.71%	41,307 $1.16 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $86,990 - $99,892	-3,360 Reduced 6.91%	45,247 $1.26 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $165,429 - $214,874	-6,331 Reduced 11.52%	48,607 $1.4 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $160,417 - $187,512	-4,999 Reduced 8.34%	54,938 $1.82 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $75,852 - $87,759	-2,100 Reduced 3.39%	59,937 $2.2 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $22,255 - $28,973	565 Added 0.92%	62,037 $2.53 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $15,322 - $20,001	-367 Reduced 0.59%	61,472 $3.15 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $187,748 - $222,610	4,035 Added 6.98%	61,839 $3.24 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $9,150 - $11,338	200 Added 0.35%	57,804 $2.99 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $200,195 - $296,756	4,845 Added 9.18%	57,604 $3.4 Million
Q3 2021 Nov 10, 2021	SELL	$39.25 - $50.42 $16,995 - $21,831	-433 Reduced 0.81%	52,759 $2.27 Million
Q2 2021 Aug 02, 2021	SELL	$35.91 - $40.68 $6,751 - $7,647	-188 Reduced 0.35%	53,192 $2.08 Million
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $31,313 - $35,314	-935 Reduced 1.72%	53,380 $1.93 Million
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $68,513 - $87,120	2,047 Added 3.92%	54,315 $2 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $18,732 - $21,977	-590 Reduced 1.12%	52,268 $1.92 Million
Q2 2020 Jul 17, 2020	BUY	$30.12 - $36.54 $160,539 - $194,758	5,330 Added 11.21%	52,858 $1.73 Million
Q1 2020 Apr 23, 2020	SELL	$27.03 - $38.62 $382,258 - $546,164	-14,142 Reduced 22.93%	47,528 $1.55 Million
Q4 2019 Jan 10, 2020	SELL	$32.92 - $37.36 $130,330 - $147,908	-3,959 Reduced 6.03%	61,670 $2.42 Million
Q3 2019 Oct 08, 2019	BUY	$32.49 - $42.13 $377,111 - $489,002	11,607 Added 21.49%	65,629 $2.36 Million
Q2 2019 Jul 10, 2019	SELL	$36.98 - $41.52 $24,961 - $28,026	-675 Reduced 1.23%	54,022 $2.34 Million
Q1 2019 Apr 09, 2019	BUY	$37.5 - $41.2 $39,787 - $43,713	1,061 Added 1.98%	54,697 $2.32 Million
Q4 2018 Jan 16, 2019	BUY	$38.47 - $43.86 $8,232 - $9,386	214 Added 0.4%	53,636 $2.34 Million
Q3 2018 Oct 12, 2018	SELL	$34.47 - $41.81 $87,105 - $105,653	-2,527 Reduced 4.52%	53,422 $2.35 Million
Q2 2018 Jul 24, 2018	BUY	$32.98 - $35.16 $149,597 - $159,485	4,536 Added 8.82%	55,949 $2.03 Million
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $331,895 - $385,045	-10,401 Reduced 16.83%	51,413 $1.83 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $188,950 - $200,482	5,681 Added 10.12%	61,814 $2.24 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.74 Million - $1.92 Million	56,133	56,133 $0

Others Institutions Holding PFE

# of Institutions

3,254

Shares Held

3.65B

Call Options Held

77.7M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.

Account

Douglass Winthrop Advisors, LLC Pfizer Inc Transaction History